Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA)
CUSIP: 04746L104
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, $0.0001 Par Value
- Shares outstanding
- 9,614,000
- Total 13F shares
- 17,548,824
- Share change
- -7,638
- Total reported value
- $5,295,638
- Put/Call ratio
- 0%
- Price per share
- $0.30
- Number of holders
- 50
- Value change
- +$4,106
- Number of buys
- 16
- Number of sells
- 13
Quarterly Holders Quick Answers
What is CUSIP 04746L104?
CUSIP 04746L104 identifies ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 04746L104:
Top shareholders of ATHA - Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
56%
|
5,402,964
|
$1,539,304 | — | 31 Mar 2025 | |
| BML Capital Management, LLC |
13F
|
Company |
33%
|
3,200,667
|
$911,870 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
16%
|
1,537,914
|
$438,306 | — | 31 Mar 2025 | |
| Propel Bio Management, LLC |
13F
|
Company |
16%
|
1,492,792
|
$425,296 | — | 31 Mar 2025 | |
| Simplify Asset Management Inc. |
13F
|
Company |
16%
|
1,492,792
|
$425,296 | — | 31 Mar 2025 | |
| Hans Moebius |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
91,482
|
$266,213 | — | 04 Jan 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
6.2%
|
600,000
|
$170,940 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
4.8%
|
457,199
|
$130,256 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
4.5%
|
428,533
|
$121,000 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
4.3%
|
416,158
|
$118,189 | — | 31 Mar 2025 | |
| Pathstone Holdings, LLC |
13F
|
Company |
3.9%
|
372,196
|
$106,039 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
3.2%
|
311,498
|
$88,773 | — | 31 Mar 2025 | |
| Bristlecone Advisors, LLC |
13F
|
Company |
2.6%
|
252,200
|
$71,852 | — | 31 Mar 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
2.3%
|
221,068
|
$62,982 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.3%
|
219,000
|
$62,393 | — | 31 Mar 2025 | |
| Andrew Gengos |
3/4/5
|
CFO and Chief Business Officer |
—
mixed-class rows
|
377,532
mixed-class rows
|
$55,203 | — | 03 Sep 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.6%
|
157,100
|
$44,758 | — | 31 Mar 2025 | |
| Laird Norton Wetherby Trust Company, LLC |
13F
|
Company |
1.3%
|
127,309
|
$36,270 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.1%
|
107,381
|
$30,593 | — | 31 Mar 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.92%
|
88,233
|
$25,000 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.8%
|
76,551
|
$21,818 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.56%
|
53,609
|
$15,273 | — | 31 Mar 2025 | |
| Clarius Group, LLC |
13F
|
Company |
0.56%
|
53,551
|
$15,257 | — | 31 Mar 2025 | |
| Integrity Financial Corp /WA |
13F
|
Company |
0.55%
|
52,902
|
$15,072 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.52%
|
49,573
|
$14,123 | — | 31 Mar 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.48%
|
46,148
|
$13,148 | — | 31 Mar 2025 | |
| Invst, LLC |
13F
|
Company |
0.47%
|
45,000
|
$12,821 | — | 31 Mar 2025 | |
| Rachel Lenington |
3/4/5
|
COO and CDO |
—
mixed-class rows
|
320,870
mixed-class rows
|
$11,812 | — | 03 Sep 2024 | |
| EASTERLY INVESTMENT PARTNERS LLC |
13F
|
Company |
0.35%
|
33,500
|
$9,544 | — | 31 Mar 2025 | |
| BRIGHTON JONES LLC |
13F
|
Company |
0.33%
|
32,200
|
$9,174 | — | 31 Mar 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.29%
|
27,500
|
$7,700 | — | 31 Mar 2025 | |
| JOURNEY STRATEGIC WEALTH LLC |
13F
|
Company |
0.21%
|
20,538
|
$5,851 | — | 31 Mar 2025 | |
| SIMON QUICK ADVISORS, LLC |
13F
|
Company |
0.21%
|
20,538
|
$5,851 | — | 31 Mar 2025 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.21%
|
20,000
|
$5,698 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.2%
|
18,753
|
$5,343 | — | 31 Mar 2025 | |
| Shay Capital LLC |
13F
|
Company |
0.19%
|
18,586
|
$5,295 | — | 31 Mar 2025 | |
| Vanguard Personalized Indexing Management, LLC |
13F
|
Company |
0.15%
|
14,165
|
$4,036 | — | 31 Mar 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.15%
|
14,154
|
$4,000 | — | 31 Mar 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.15%
|
14,077
|
$4,000 | — | 31 Mar 2025 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.13%
|
12,697
|
$3,617 | — | 31 Mar 2025 | |
| Engineers Gate Manager LP |
13F
|
Company |
0.11%
|
11,042
|
$3,146 | — | 31 Mar 2025 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
11,000
|
$3,134 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.1%
|
9,547
|
$2,720 | — | 31 Mar 2025 | |
| Lindbrook Capital, LLC |
13F
|
Company |
0.09%
|
8,920
|
$2,541 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
5,112
|
$1,456 | — | 31 Mar 2025 | |
| COLDSTREAM CAPITAL MANAGEMENT INC |
13F
|
Company |
0.03%
|
2,640
|
$753 | — | 31 Mar 2025 | |
| American Capital Advisory, LLC |
13F
|
Company |
0.02%
|
2,000
|
$570 | — | 31 Mar 2025 | |
| ROTHSCHILD INVESTMENT LLC |
13F
|
Company |
0.02%
|
1,500
|
$427 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.01%
|
1,361
|
$388 | — | 31 Mar 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.01%
|
831
|
$237 | — | 31 Mar 2025 |
Institutional Holders of Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) as of Q2 2025
As of 30 Jun 2025,
Athira Pharma, Inc. - Common Stock, $0.0001 Par Value (ATHA) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,548,824 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, BML Capital Management, LLC, VANGUARD GROUP INC, Propel Bio Management, LLC, Simplify Asset Management Inc., TANG CAPITAL MANAGEMENT LLC, BANK OF AMERICA CORP /DE/, ACADIAN ASSET MANAGEMENT LLC, BlackRock, Inc., and Pathstone Holdings, LLC.
This page lists
51
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
52
Q2 2025 holders
50
Holder diff
-2
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.